4.8 Article

Stac3 has a direct role in skeletal muscle-type excitation-contraction coupling that is disrupted by a myopathy-causing mutation

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1612441113

关键词

L-type Ca2+ channels; Stac3 protein; excitation-contraction coupling

资金

  1. NIH [AR055104, AR052354, HL-077439, HL-111665, HL-093039, DK-099653, U01-HL-100401]
  2. Muscular Dystrophy Association [MDA176448]
  3. Robert A. Welch Foundation [1-0025]

向作者/读者索取更多资源

In skeletal muscle, conformational coupling between Ca(v)1.1 in the plasma membrane and type 1 ryanodine receptor (RyR1) in the sarcoplasmic reticulum (SR) is thought to underlie both excitation-contraction (EC) coupling Ca2+ release from the SR and retrograde coupling by which RyR1 increases the magnitude of the Ca2+ current via Ca(v)1.1. Recent work has shown that EC coupling fails in muscle from mice and fish null for the protein Stac3 (SH3 and cysteine-rich domain 3) but did not establish the functional role of Stac3 in the Ca(v)1.1-RyR1 interaction. We investigated this using both tsA201 cells and Stac3 KO myotubes. While confirming in tsA201 cells that Stac3 could support surface expression of Ca(v)1.1 (coexpressed with its auxiliary beta(1a) and alpha(2)-delta(1) subunits) and the generation of large Ca2+ currents, we found that without Stac3 the auxiliary gamma(1) subunit also supported membrane expression of Ca(v)1.1/beta(1a)/alpha(2)-delta(1), but that this combination generated only tiny Ca2+ currents. In Stac3 KO myotubes, there was reduced, but still substantial Ca(v)1.1 in the plasma membrane. However, the Ca(v)1.1 remaining in Stac3 KO myotubes did not generate appreciable Ca2+ currents or EC coupling Ca2+ release. Expression of WT Stac3 in Stac3 KO myotubes fully restored Ca2+ currents and EC coupling Ca2+ release, whereas expression of Stac3(W280S) (containing the Native American myopathy mutation) partially restored Ca2+ currents but only marginally restored EC coupling. We conclude that membrane trafficking of Ca(v)1.1 is facilitated by, but does not require, Stac3, and that Stac3 is directly involved in conformational coupling between Ca(v)1.1 and RyR1.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

RBPMS is an RNA-binding protein that mediates cardiomyocyte binucleation and cardiovascular development

Peiheng Gan, Zhaoning Wang, Maria Gabriela Morales, Yu Zhang, Rhonda Bassel-Duby, Ning Liu, Eric N. Olson

Summary: This study identified a genetic defect associated with noncompaction cardiomyopathy and revealed some underlying mechanisms. The loss of Rbpms gene led to premature cardiomyocyte binucleation and cell cycle arrest, in which Rbpms mediated the isoform switching of a specific protein.

DEVELOPMENTAL CELL (2022)

Article Medicine, Research & Experimental

Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice

Dileep R. Karri, Yu Zhang, Francesco Chemello, Yi-Li Min, Jian Huang, Jiwoong Kim, Pradeep P. A. Mammen, Lin Xu, Ning Liu, Rhonda Bassel-Duby, Eric N. Olson

Summary: This study demonstrates the long-term durability of CRISPR/Cas9 genome editing as a therapy for maintaining the integrity and function of DMD muscle, even under conditions of stress.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Cardiac & Cardiovascular Systems

CRISPR Modeling and Correction of Cardiovascular Disease

Ning Liu, Eric N. Olson

Summary: Cardiovascular disease is the leading cause of deaths and illnesses in developed countries. Mouse models have played a significant role in studying the complex signaling pathways, genetic and epigenetic regulations, and multicellular interactions involved in cardiovascular disease. The advent of CRISPR genome editing has revolutionized cardiovascular research, allowing for rapid modeling and potential genetic correction of disease-causing mutations.

CIRCULATION RESEARCH (2022)

Article Geriatrics & Gerontology

Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy

Mina Shahriyari, Md Rezaul Islam, Sadman M. Sakib, Malte Rinn, Anastasia Rika, Dennis Krueger, Lalit Kaurani, Verena Gisa, Mandy Winterhoff, Harithaa Anandakumar, Orr Shomroni, Matthias Schmidt, Gabriela Salinas, Andreas Unger, Wolfgang A. Linke, Jana Zschuentzsch, Jens Schmidt, Rhonda Bassel-Duby, Eric N. Olson, Andre Fischer, Wolfram-Hubertus Zimmermann, Malte Tiburcy

Summary: This study successfully established methods for deriving skeletal muscle cells from human pluripotent stem cells and engineered a functional human skeletal muscle organoid and engineered skeletal muscle with regeneration-competent satellite-like cells. Contractile performance of the engineered muscle was further enhanced by thyroid hormone treatment.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Article Medicine, Research & Experimental

A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing

Yu Zhang, Hui Li, Takahiko Nishiyama, John R. McAnally, Efrain Sanchez-Ortiz, Jian Huang, Pradeep P. A. Mammen, Rhonda Bassel-Duby, Eric N. Olson

Summary: In this study, a humanized DMD mouse model was created to evaluate the efficacy of CRISPR-Cas9 gene editing for DMD correction. The model successfully restored dystrophin expression and improved pathological features and muscle strength. This model provides a valuable tool for assessing clinically relevant gene editing strategies and advancing the therapeutic translation of CRISPR-Cas9 gene editing for DMD correction.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Cell Biology

Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy

Takahiko Nishiyama, Yu Zhang, Miao Cui, Hui Li, Efrain Sanchez-Ortiz, John R. McAnally, Wei Tan, Jiwoong Kim, Kenian Chen, Lin Xu, Rhonda Bassel-Duby, Eric N. Olson

Summary: Mutations in the RBM20 gene are a common cause of familial dilated cardiomyopathy. The study uses gene editing techniques to correct these mutations and demonstrates that correction can restore normal gene splicing and nuclear localization, while eliminating abnormal ribonucleoprotein granule formation. The effectiveness of this therapy is also validated in a mouse model.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Immunology

Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies

Ildiko Bock-Marquette, Klaudia Maar, Szabolcs Maar, Balint Lippai, Gabor Faskerti, Ferenc Gallyas, Eric N. Olson, Deepak Srivastava

Summary: Our dream of defeating the processes of organ damage and aging remains a challenge, and steps towards regenerating individual organs are considered significant. Through interconnecting our collective knowledge regarding aging and embryonic development, we propose to discover molecules that can effectively reverse cellular damage. Our results regarding Thymosin beta-4 (TB4) support this hypothesis, showing its potential to promote cardiac cell migration and survival, enhance myocyte survival and improve cardiac function, and activate epicardial progenitor cells.

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

Loss Of Function Of The Nuclear Envelope Protein LEMD2 Causes DNA Damage-dependent Cardiomyopathy

Xurde M. Caravia, Andres Ramirez-Martinez, Peiheng Gan, John R. McAnally, Rhonda Bassel-Duby, Ning Liu, Eric N. Olson

CIRCULATION RESEARCH (2022)

Article Medicine, Research & Experimental

Loss of function of the nuclear envelope protein LEMD2 causes DNA damage-dependent cardiomyopathy

Xurde M. Caravia, Andres Ramirez-Martinez, Peiheng Gan, Feng Wang, John R. McAnally, Lin Xu, Rhonda Bassel-Duby, Ning Liu, Eric N. Olson

Summary: Mutations in nuclear envelope proteins cause devastating genetic diseases that primarily affect the heart and skeletal muscle. This study reveals the essentiality of LEMD2 for genome stability and cardiac function, and uncovers its mechanistic association with human disease. Gene therapy targeting Lemd2 can rescue the disease phenotype.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

The Nuclear Transcription Factor Y Controls Cell-cycle And Metabolic Gene Transcription During Cardiac Development

Miao Cui, Ning Liu, Rhonda S. Bassel-Duby, Eric N. Olson

CIRCULATION RESEARCH (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

RBPMS, An RNA-binding Protein That Mediates Cardiomyocyte Binucleation And Cardiovascular Development

Peiheng Gan, Rhonda S. Bassel-Duby, Ning Liu, Eric N. Olson

CIRCULATION RESEARCH (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

S100A1 And STRIT1 Redundantly Governs Responsiveness Of The Heart To Hemodynamic Stress Via Modulation Of SERCA2a Activity

Zegeye Hailu Jebessa, Andrea Schneider, Matthias Dewenter, Michael Berlin, Catherine A. Makarewich, Eric N. Olson, Marc Freichel, Martin Busch, Johannes Backs, Patrick Most

CIRCULATION RESEARCH (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

Precise Genomic Correction of RBM20 Mutations Rescues Dilated Cardiomyopathy

Takahiko Nishiyama, Yu Zhang, John Mcanally, Lin Xu, Ning Liu, Rhonda S. Bassel-Duby, Eric N. Olson

CIRCULATION (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

DWORF diminishes clustering of phospholamban in a PLN-R14del cardiomyopathy mouse model and extends life span

N. M. Stege, T. R. Eijgenraam, V. Oliveira Nunes Teixeira, A. M. Feringa, E. M. Schouten, C. A. Makarewich, R. Bassel-Duby, E. N. Olson, R. A. De Boer, H. H. W. Sillje

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

Enhancing cardiac regenerative therapies by reminding the adult heart on its embryonic state

I. Bock-Marquette, K. Maar, S. Maar, B. Lippai, G. Faskerti, D. Hanna, J. Thatcher, E. N. Olson, F. Gallyas

EUROPEAN JOURNAL OF HEART FAILURE (2022)

暂无数据